Stanol 50 mg Selliza Pharma

Description

This Selliza Pharma winstrol at 50 mg provides a dry, strength-focused anabolic signal. Best deployed in the final 6–8 weeks of a cutting cycle. Liver support (TUDCA 500 mg/day) if oral.

Key Benefits

• 17α-alkylated DHT-derivative — zero aromatisation, no water retention
• Significant SHBG reduction — frees up more bound testosterone on cycle
• Dramatic strength and hardness gains without scale-weight bloat
• Available oral OR aqueous injectable — same molecule, different kinetics
• Cutting and pre-contest staple when dry, vascular look is the goal
• Each unit dosed at 50 mg — see Recommended Dosage below for protocol-specific intake

Recommended Dosage

Research dosing: oral 25–50 mg/day for 6–8 weeks, or injectable 50 mg every other day. Women 5–10 mg/day oral, short cycles only (4 weeks) — virilisation risk rises sharply beyond that. Above 50 mg/day SHBG crashes hard and joint dryness becomes limiting.

How It Works

17α-alkylated DHT-derivative. Does not aromatise. Distinctive mechanism: significant SHBG reduction that frees more co-administered testosterone to bind the AR. Minimal progestagenic activity. Androgenic effects at typical dose are low, but hair-follicle impact in genetically predisposed users is measurable.

Pharmacokinetics

Oral half-life ~9 hours; aqueous-suspension injectable ~24 hours. The injectable is the same molecule as the tablet — the suspension simply bypasses first-pass liver metabolism. Hepatotoxicity similar between routes since the 17α-alkyl group is preserved in both. ALT/AST at week 4.

Potential Side Effects

Joint pain from reduced synovial fluid is the signature complaint — fish oil 4 g/day helps. Lipid panel takes a big hit (HDL drops 30–50%). Androgenic side-effects dose-dependent. Liver markers rise; mandatory TUDCA support.

Cycle & Stacking Guide

Cutting and pre-contest hardening, 6–8 weeks. Standard stack: test base + stanozolol + trenbolone or masteron. Not a mass-builder — use methandienone or oxymetholone for that role. Avoid heavy pressing during cycle if joints are pre-compromised.

Manufacturer Notes

Selliza Pharma focuses on injectable blends with standardised concentrations. Tamper-evident vial caps; batch-date coded labels.

Storage & Handling

Store in the original blister or bottle at 15–25 °C, away from direct sunlight, heat, and humidity. Oral preparations lose potency faster if exposed to moisture; keep the desiccant (if included) with the tablets. Keep out of reach of children. For research and educational purposes only.